The Relationship of SP and AP Findings to Hearing Level in Meniere's Disease

1988 ◽  
Vol 17 (4) ◽  
pp. 237-240 ◽  
Author(s):  
N. Mori ◽  
H. Asai ◽  
M. Sakagami
1999 ◽  
Vol 113 (3) ◽  
pp. 217-221 ◽  
Author(s):  
Levent Sennaroğlu ◽  
Farzin Mottaghian Dini ◽  
Gonca Sennaroğlu ◽  
Bulent Gursel ◽  
Soner Ozkan

AbstractThe aetiology of Ménière's disease still remains unknown and its therapy is therefore empirical. As a result of immunological abnormalities demonstrated, steroids are commonly used in Ménière's disease. The place of topical steroids is still controversial. In this investigation topical dexamethasone is applied for three months through a ventilation tube in patients with intractable vertigo. The results showed that this treatment controls vertigo in 72 per cent of cases. No patient was worse than before treatment. Only in 17 per cent of the patients was there an increase in hearing level. When compared to the reports which used only tympanostomy tubes, this procedure seems to have a placebo effect with minimal harmful effects. It appears that transtympanic dexamethasone application is a good alternative to vestibular nerve section. Topical treatment may be sufficient in most patients. Systemic treatment may be used in patients where topical treatment fails.


2022 ◽  
pp. 1-7

OBJECTIVE When Ménière’s disease (MD) becomes disabling due to the frequency of attacks or the appearance of drop attacks (i.e., Tumarkin otolithic crisis) despite "conservative" medical and surgical treatments, a radical treatment like vestibular neurotomy (VN) is possible. An ideal MD treatment would relieve symptoms immediately and persist after the therapy. The aim of this study was to identify if VN was effective after 10 years of follow-up regarding vertigo and drop attacks, and to collect the immediate complications. METHODS The authors report a retrospective, single-center (i.e., in a single tertiary referral center with otoneurological surgery activity) cohort study conducted from January 2003 to April 2020. All patients with unilateral disabling MD who had received a VN with at least 10 years of follow-up were included. The therapeutic efficacy was defined by complete disappearance of vertigo and drop attacks. The postoperative complications (CSF leak, total deafness, meningitis, death) were determined immediately after the surgery, and the hearing thresholds were determined during the patient follow-up with the pure tone average (PTA). RESULTS A total of 74 patients (of 85 who were eligible), average age 51.9 ± 11.1 years, including 38 men (51.4%), with disabling MD and/or Tumarkin drop attacks (24.3%) received VN, with at least 10 years of follow-up after surgery. After an average follow-up of 12.4 ± 1.7 years (range 10.0–16.3 years), 67 patients (90.5%) no longer presented any vertiginous attacks, and no patient experienced drop attack. The mean variation in early pre- and postoperative PTA was not statistically significant (n = 64, 2.2 ± 10.3 decibels hearing level [range −18 to 29], 95% CI [−0.4 to 4.37]; p = 0.096), and 84.4% of the patients evaluated had unchanged or improved postoperative PTA. Three significant complications were noted, including two surgical revisions for CSF leak. There was no permanent facial paralysis, meningitis, or death. CONCLUSIONS In case of disabling MD (disabling vertigo refractory to conservative vestibular treatments—Tumarkin drop attacks), VN via the retrosigmoid approach must be the prioritized proposal in comparison to intratympanic gentamicin injections, because of the extremely low complication rate and the immediate and long-lasting effect of this treatment on vertigo and falls.


1983 ◽  
Vol 11 (01n04) ◽  
pp. 102-105 ◽  
Author(s):  
Antun Steinberger ◽  
Mihovil Pansini

34 patients suffering from Meniere's disease were treated by acupuncture. Prior to acupuncture most of them had been treated with various other medical means without satisfactory results. After acupuncture treatment their condition greatly improved. The classic symptoms of Meniere's disease are vertigo, tinnitus and deafness, but for all the treated patients vertigo was the most uncomfortable and distressing symptom. In all our cases vertigo stopped after a few acupuncture courses; but in our opinion it is more important to follow and control hearing threshold, since if it remains stable the other symptoms of Meniere's disease also do not persist. All our patients were regularly followed by careful audiometric studies several years after acupuncture treatment. In most cases hearing level had not greatly varied, so the other symptoms of Meniere's disease were not present in any large degree.


2020 ◽  
Vol 79 (3) ◽  
pp. 125-132
Author(s):  
Akihiro Kishino ◽  
Shuntaro Shigihara ◽  
Yasuyuki Nomura ◽  
Takeshi Oshima

Author(s):  
Tessei Kuruma ◽  
Mariko Arimoto ◽  
Mayuko Kishimoto ◽  
Yasue Uchida ◽  
Tetsuya Ogawa ◽  
...  

<p class="abstract"><strong>Background:</strong> This study aimed to clarify the effects of transtympanic tube insertion on patients with Meniere’s disease refractory to conservative treatment.</p><p class="abstract"><strong>Methods:</strong> Between January 2010 and December 2019, 40 patients with refractory Meniere’s disease were assigned to group I, a group of 19 patients who underwent transtympanic tube insertion (13 males, 6 females; age range 15-79 years) and group II, a control group of 21 patients who did not undergo intratympanic tube insertion (10 males, 11 females; age range 26-81 years). Definitive vertigo spells, hearing level, tinnitus and aural fullness were assessed for 2 years after treatment. The effectiveness of treatment for vertigo attacks and hearing loss was assessed according to the 1995 American academy of otolaryngology-head and neck surgery criteria. The degree of disability due to vertiginous attacks was also assessed and compared between groups using the dizziness handicap inventory (DHI) before and 2 years after treatment.</p><p class="abstract"><strong>Results:</strong> The frequency of vertigo attacks and the DHI score were significantly better in group I than in group II 2 years after treatment. Group I also showed significantly improved tinnitus and feelings of fullness. However, the hearing level remained unaffected in both groups.</p><p><strong>Conclusions:</strong> This less invasive treatment might offer short term efficacy in reducing persistent vertigo, tinnitus and a feeling of aural fullness for some patients with Meniere’s disease. </p>


Sign in / Sign up

Export Citation Format

Share Document